Codexis CDXS
NASDAQ CDXS
$1.67 +0.09 (+5.70%)
At close: Aug 21, 2026 · 4:00 PM EDT

Codexis (CDXS) Gross Margin (2010 - 2026)

Codexis (CDXS) posted quarterly Gross Margin of 86.46% for Q1 2026, up 2268.0% year-over-year from 3.65% in Q1 2025, and down 8.75% quarter-over-quarter from 94.75% in Q4 2025.

Codexis (CDXS) Gross Margin (2010 - 2026) Analysis & Trends

Codexis' Gross Margin history runs 17 years deep, the most recent figure standing at 86.46% for Q1 2026.

  • In Q1 2026, Gross Margin rose 2268.0% year-over-year to 86.46%; the TTM figure through Mar 2026 stood at 88.9% (up 1733.0% YoY), while the FY2025 annual figure was 86.73%, up 1418.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 86.46%, down from 94.75% in the prior quarter.
  • The five-year high for Gross Margin was 94.75% in Q4 2025, with the low at 36.44% in Q2 2023.
  • The 5-year median for Gross Margin is 71.34% (2025), against an average of 69.16%.
  • The sharpest annual moves came in 2023 and 2024: Gross Margin plunged 3422 bps in 2023, then surged 4021 bps in 2024.
  • Codexis' Gross Margin stood at 57.29% in 2022, then declined by 25 bps to 42.76% in 2023, then surged by 94 bps to 82.97% in 2024, then grew by 14 bps to 94.75% in 2025, then declined by 9 bps to 86.46% in 2026.
  • Business Quant data shows CDXS's Gross Margin at 86.46% in Q1 2026, 94.75% in Q4 2025, and 71.34% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 85.33%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 91.59%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 90.43%
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 35.86%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 89.76%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 76.90%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 63.27%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 84.20%
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Codexis 152.06 Mn 97.14 Mn 11.40 Mn 76.45%

Historic Data

Download Data
DateValue
Jun 30, 2026 76.45%
Mar 31, 2026 86.46%
Dec 31, 2025 94.75%
Sep 30, 2025 71.34%
Jun 30, 2025 86.31%
Mar 31, 2025 63.78%
Dec 31, 2024 82.97%
Sep 30, 2024 66.36%
Jun 30, 2024 56.61%
Mar 31, 2024 71.56%
Dec 31, 2023 42.76%
Sep 30, 2023 75.76%
Jun 30, 2023 36.44%
Mar 31, 2023 65.17%
Dec 31, 2022 57.29%
Sep 30, 2022 71.61%
Jun 30, 2022 70.66%
Mar 31, 2022 75.89%
Dec 31, 2021 72.22%
Sep 30, 2021 81.32%